Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze

Neurotoxicology and Teratology

Volumn 31, Issue 1, 2009, Pages 1-10

  Vorhees, Charles V ^a   Johnson, Holly L ^a   Burns, Lindsey N ^a   Williams, Michael T ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Development; Dopamine D2 3 agonist; Dopamine D2 3 receptors; Learning and memory; Quinpirole; Rat; Spatial learning

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; METHAMPHETAMINE; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPTH PERCEPTION; DEVELOPMENTAL STAGE; DRUG EFFECT; FEMALE; LEARNING DISORDER; LOCOMOTION; MALE; MAZE TEST; MOTOR ACTIVITY; NONHUMAN; PERINATAL PERIOD; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT;

ANIMALS; ANXIETY; BODY WEIGHT; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; EXPLORATORY BEHAVIOR; FEMALE; IMPULSIVE BEHAVIOR; MAZE LEARNING; METHAMPHETAMINE; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SPACE PERCEPTION; STARTLE REACTION;

RATTUS;

EID: 57249095720     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.09.003     Document Type: Article

References (40)

1. Battle Y.L., Martin B.C., Dorfman J.H., and Miller L.S. Seasonality and infectious disease in schizophrenia: the birth hypothesis revisited. J. Psychiatr. Res. 33 (1999) 501-509
2. Broening H.W., Morford L.L., Inman-Wood S.L., Fukumura M., and Vorhees C.V. 3,4-methylenedioxymethamphetamine (ecstasy) induced learning and memory impairments depend on the age of exposure during early development. J. Neurosci. 21 (2001) 3228-3235
3. Brown R.W., Gass J.T., and Kostrzewa R.M. Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats. Pharmacol. Biochem. Behav. 72 (2002) 591-600
4. Brown R.W., Flanigan T.J., Thompson K.N., Thacker S.K., Schaefer T.L., and Williams M.T. Neonatal quinpirole treatment impairs Morris water task performance in early postweanling rats: relationship to increases in corticosterone and decreases in neurotrophic factors. Biol. Psychiatry 56 (2004) 161-168
5. Brown R.W., Thompson K.D., Thompson K.N., Ward J.J., Thacker S.K., Williams M.T., and Kostrzewa R.M. Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: possible roles of acetylcholine function and neurotrophic factor expression. Eur. J. Neurosci. 19 (2004) 1634-1642
6. Brown R.W., Thompson K.N., Click I.A., Best R.A., Thacker S.K., and Perna M.K. The effects of eticlopride on Morris water task performance in male and female rats neonatally treated with quinpirole. Psychopharmacology (Berl) 180 (2005) 234-240
7. Brown R.W., Perna M.K., Schaefer T.L., and Williams M.T. The effects of adulthood nicotine treatment on D2-mediated behavior and neurotrophins of rats neonatally treated with quinpirole. Synapse 59 (2006) 253-259
8. Commins S., Cunningham L., Harvey D., and Walsh D. Massed but not spaced training impairs spatial memory. Behav. Brain Res. 139 (2003) 215-223
9. Crawley J.N. What's Wrong with My Mouse? Behavioral Phenotyping of Transgenic and Knockout Mice (2000), Wiley-Liss, New York
10. Erbel-Sieler C., Dudley C., Zhou Y., Wu X., Estill S.J., Han T., Diaz-Arrastia R., Brunskill E.W., Potter S.S., and McKnight S.L. Behavioral and regulatory abnormalities in mice deficient in the NPAS1 and NPAS3 transcription factors. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 13648-13653
11. Harrison P.J. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 122 Pt 4 (1999) 593-624
12. Knable M.B., Torrey E.F., Webster M.J., and Bartko J.J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res. Bull. 55 (2001) 651-659
13. Konradi C., and Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol. Ther. 97 (2003) 153-179
14. Kostrzewa R.M. Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev. 19 (1995) 1-17
15. Maple A.M., Perna M.K., Woodruff M.L., and Brown R.W. Deficits in prepulse inhibition in a rodent model of schizophrenia are alleviated through pretreatment with nicotine. Soc. Neurosci. Abst. 35 975 (2005) 1
16. Morford L.L., Inman-Wood S.L., Gudelsky G.A., Williams M.T., and Vorhees C.V. Impaired spatial and sequential learning in rats treated neonatally with d-fenfluramine. Eur. J. Neurosci. 16 (2002) 491-500
17. Morris R.G.M. Spatial localization does not require the presence of local cues. Learn. Motiv. 12 (1981) 239-260
18. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
19. Njunge'e K., and Handley S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav. 38 (1991) 63-67
20. Sawa A., and Snyder S.H. Schizophrenia: diverse approaches to a complex disease. Science 296 (2002) 692-695
21. Shepherd J.K., Grewal S.S., Fletcher A., Bill D.J., and Dourish C.T. Behavioural and pharmacological characterization of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology 116 (1994) 56-64
22. Stewart C.A., and Morris R.G.M. The watermaze. In: Sahgal A. (Ed). A Practical Approach. Behavioural Neuroscience vol. I (1993), IRL Press at Oxford University Press, Oxford 107-122
23. Thacker S.K., Perna M.K., Ward J.J., Schaefer T.L., Williams M.T., Kostrzewa R.M., and Brown R.W. The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole. Eur. J. Neurosci. 24 (2006) 2075-2083
24. Vorhees C.V. Maze learning in rats: a comparison of performance in two Water mazes in progeny prenatally exposed to different doses of phenytoin. Neurotoxicol. Teratol. 9 (1987) 235-241
25. Vorhees C.V., Ahrens K.G., Acuff-Smith K.D., Schilling M.A., and Fisher J.E. Methamphetamine exposure during early postnatal development in rats: I. Acoustic startle augmentation and spatial learning deficits. Psychopharmacology 114 (1994) 392-401
26. Vorhees C.V., Reed T.M., Schilling M.A., Fisher J.E., Moran M.S., Cappon G.D., and Nebert D.W. CYP2D1 polymorphism in methamphetamine-treated rats: genetic differences in neonatal mortality and a comparison of spatial learning and acoustic startle. Neurotoxicol. Teratol. 20 (1998) 265-273
27. Vorhees C.V., Morford L.L., Inman S.L., Reed T.M., Schilling M.A., Cappon G.D., Moran M.S., and Nebert D.W. Genetic differences in spatial learning between Dark Agouti and Sprague-Dawley strains: possible correlation with CYP2D2 polymorphism in rats treated neonatally with methamphetamine. Pharmacogenetics 9 (1999) 171-181
28. Vorhees C.V., Inman-Wood S.L., Morford L.L., Broening H.W., Fukumura M., and Moran M.S. Adult learning deficits after neonatal exposure to D-methamphetamine: selective effects on spatial navigation and memory. J. Neurosci. 20 (2000) 4732-4739
29. Vorhees C.V., Reed T.M., Skelton M.R., and Williams M.T. Exposure to 3,4-methylenedioxymethamphetamine (MDMA) on postnatal days 11-20 induces reference but not working memory deficits in the Morris water maze in rats: implications of prior learning. Int. J. Dev. Neurosci. 22 (2004) 247-259
30. Vorhees C.V., and Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc. 1 (2006) 848-858
31. Vorhees C.V., Schaefer T.L., and Williams M.T. Developmental effects of +/-3,4-methylenedioxymethamphetamine on spatial versus path integration learning: effects of dose distribution. Synapse 61 (2007) 488-499
32. Vorhees C.V., Skelton M.R., and Williams M.T. Age-dependent effects of neonatal methamphetamine exposure on spatial learning. Behav. Pharmacol. 18 (2007) 549-562
33. Vorhees C.V., Herring N.R., Schaefer T.L., Grace C.E., Skelton M.R., Johnson H.L., and Williams M.T. Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int. J. Dev. Neurosci. 26 (2008) 599-610
34. Watson C.G., Kucala T., Tilleskjor C., and Jacobs L. Schizophrenic birth seasonality in relation to the incidence of infectious diseases and temperature extremes. Arch. Gen. Psychiatry 41 (1984) 85-90
35. Williams M.T., Vorhees C.V., Boon F., Saber A.J., and Cain D.P. Methamphetamine exposure from postnatal days 11 to 20 causes impairments in both behavioral strategies and spatial learning in adult rats. Brain Res. 958 (2002) 312-321
36. Williams M.T., Blankenmeyer T.L., Schaefer T.L., Brown C.A., Gudelsky G.A., and Vorhees C.V. Long-term effects of neonatal methamphetamine exposure in rats on spatial learning in the Barnes maze and on cliff avoidance, corticosterone release, and neurotoxicity in adulthood. Dev. Brain Res. 147 (2003) 163-175
37. Williams M.T., Moran M.S., and Vorhees C.V. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology 168 (2003) 329-338
38. Williams M.T., Morford L.L., Wood S.L., Rock S.L., McCrea A.E., Fukumura M., Wallace T.L., Broening H.W., Moran M.S., and Vorhees C.V. Developmental 3,4-methylenedioxymethamphetamine (MDMA) impairs sequential and spatial but not cued learning independent of growth, litter effects, or injection stress. Brain Research 968 (2003) 89-101
39. Williams M.T., Morford L.L., Wood S.L., Wallace T.L., Fukumura M., Broening H.W., and Vorhees C.V. Developmental d-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse 48 (2003) 138-148
40. Williams M.T., Moran M.S., and Vorhees C.V. Behavioral and growth effects induced by low dose methamphetamine administration during the neonatal period in rats. Int. J. Dev. Neurosci. 22 (2004) 273-283